These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3036536)

  • 1. In vitro chemosensitivity of human lung cancer for vindesine.
    De Vries EG; Meijer C; Mulder NH; Postmus PE
    Eur J Cancer Clin Oncol; 1987 Jan; 23(1):55-60. PubMed ID: 3036536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of vindesine in patients with non-small cell lung cancer.
    Fujita J; Saijo N; Eguchi K; Shinkai T; Tominaga K; Sasaki Y; Futami H; Sakurai M; Ishihara J; Takahashi H
    Jpn J Cancer Res; 1985 Sep; 76(9):902-5. PubMed ID: 2997097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonogenic cell assay for carcinoma of the lung.
    Kanzawa F; Hoshi A; Shimizu E; Saijo N; Miyazawa N; Shimabukuro Z
    Gan; 1984 Jan; 75(1):81-8. PubMed ID: 6327452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.
    Hutcheon AW; Palmer JB; Pratt MA; Clark RA
    Cancer Treat Rep; 1983 Nov; 67(11):1041-2. PubMed ID: 6315231
    [No Abstract]   [Full Text] [Related]  

  • 5. Vindesine in the treatment of squamous cell carcinoma (WHO I), adenocarcinoma (WHO III), and large cell carcinoma (WHO IV) of the lung.
    Ferrazzi E; Zagonel V; Vinante O; Galligioni E; Pappagallo GL; Cartei G; Fiorentino MV
    Tumori; 1982 Dec; 68(6):531-5. PubMed ID: 6301122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Update of human tumor clonogenic assay in carcinoma of the lung].
    Kanzawa F
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1552-9. PubMed ID: 2992395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a new drug 7-N-(p-hydroxyphenyl)-mitomycin C [KW 2083] against carcinoma of the lung by the human tumor clonogenic assay.
    Kanzawa F; Matsushima Y; Hoshi A; Shimizu E; Saijo N; Miyazawa N
    Invest New Drugs; 1985; 3(4):341-7. PubMed ID: 3003004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of non-small cell bronchial cancer with high-dosage cisplatin and vindesine. Results of a prospective study].
    König HJ; Arnold E; Walter M; Sander U
    Fortschr Med; 1984 Sep; 102(33):811-4. PubMed ID: 6090286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A phase II study of vindesine for pretreated non-small cell lung cancer].
    Shimizu E; Nakamura Y; Yamasaki K; Kimura K; Inoue I; Nakahira S; Kawahito K; Tani K; Sone S; Yamashita T
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2532-6. PubMed ID: 3039921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vindesine in the treatment of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lung.
    Osterlind K; Hørbov S; Dombernowsky P; Rørth M; Hansen HH
    Cancer Treat Rep; 1982 Feb; 66(2):305-9. PubMed ID: 7055816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effect of two-drug simultaneous or sequential use of cisplatin, vindesine or etoposide on human pulmonary adenocarcinoma cell lines in tumor clonogenic assay.
    Lee YC; Saijo N; Sasaki Y; Takahashi H; Sakurai M; Ishihara J; Sano T; Hoshi A; Chen KM; Hamburger AW
    Jpn J Cancer Res; 1986 Mar; 77(3):312-8. PubMed ID: 3084421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of vindesine in the treatment of small-cell lung cancer. A phase II study.
    Morgan DA
    Cancer Chemother Pharmacol; 1986; 18(2):172-3. PubMed ID: 3024858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer chemotherapy. Response-survival relationship depends on the method of chest tumor response evaluation.
    Pujol JL; Parrat E; Lehmann M; Gautier V; Daurès JP; Michel FB; Godard P
    Am J Respir Crit Care Med; 1996 Jan; 153(1):243-9. PubMed ID: 8542123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trial of vindesine plus mitomycin in stage-3 non-small cell lung cancer. An active regimen for outpatient treatment.
    Kris MG; Gralla RJ; Kelsen DP; Casper ES; Burke MT; Fiore JJ; Cibas IR; Heelan RT
    Chest; 1985 Mar; 87(3):368-72. PubMed ID: 2982552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro determination of the sensitivity of lung tumors to different drugs].
    Berzin'sh IuA; Grants EA; Murnietse EV; Zitare IIa
    Eksp Onkol; 1985; 7(1):56-8. PubMed ID: 2983973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of metastatic non-small cell bronchogenic carcinoma.
    Hoffman PC; Bitran JD; Golomb HM
    Semin Oncol; 1983 Mar; 10(1):111-22. PubMed ID: 6301062
    [No Abstract]   [Full Text] [Related]  

  • 17. [Phase II study of vindesine in patients with carcinoma of the lung and metastatic pulmonary tumor].
    Shibuya M; Saijo N; Shimizu E; Eguchi K; Shinkai T; Tominaga K; Shimabukuro Z
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1808-13. PubMed ID: 6307176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vindesine in bronchogenic carcinoma: a phase II trial.
    Vogelzang NJ; Peterson BA; Kennedy BJ; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1982 Feb; 5(1):41-4. PubMed ID: 6282107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer.
    Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Futami H
    Cancer Treat Rep; 1985 Sep; 69(9):945-51. PubMed ID: 2992785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antitumor activity of teniposide against carcinoma of the lung in human tumor clonogenic assay.
    Matsushima Y; Kanzawa F; Miyazawa N; Sasaki Y; Saijo N
    Anticancer Res; 1986; 6(5):921-4. PubMed ID: 3026235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.